Conclusion
RFA has been shown to provide oncologically effective cancer control in
the presence of
international literature and in our series, with short, medium and long
follow-up studies.
MWA-related studies will take place more in the literature in the near
future. Today,
extirpative treatments (partial nephrectomy, radical nephrectomy) are
the gold standard
method for the treatment of T1a renal cancer. However, for this
treatment approach to be
used more frequently in routine practice, more comprehensive, long-term
results and
prospective design studies are needed. As the long-term consequences of
these methods arise,
the location of ablative techniques in the treatment of renal tumors
will become even clearer.